R&D and Business Tracker for Antibody-Drug Conjugates

Friday, November 4, 2016 Drug News
Email Print This Page Comment
Font : A-A+

LONDON, Nov. 3, 2016 /PRNewswire/ -- R&D and Business Tracker for Antibody-Drug Conjugates - a monthly update service

This information service about Antibody-Drug Conjugates (ADCs) delivers 12 monthly update reports in pdf format by e-mail straight to your desk and provides online access to La Merie Publishing's R&D database for the subject field

of the service during the one-year subscription period. Credentials to access the online database will be sent by e-mail within 24 hours after purchase.

This product consists of:

  • 12 monthly update reports in pdf format delivered by e-mail; and
  • online access to ADC R&D database during the 1-year subscription period.

Download our pilot issue as a sample of the monthly pdf update report: R&D and Business Tracker sample issue for Antibody-Drug Conjugates.

The monthly update report about Antibody-Drug Conjugates contains:

R&D and Technology Tracker

  • Pipeline changes
  • Regulatory news
  • Technology validations

Business Tracker for:

  • Company updates
  • Collaboration
  • Licensing
  • Merger & acquisitions
  • Financing

Clinical Trial TrackerScientific Publication TrackerFeatured Cell Therapy ProfileFeatured Company ProfileFeatured Target or Technology Pipeline

Methodology:Information released during the previous month is retrieved from a variety of sources including corporate press releases and statements, quarterly company business reports, SEC filings, company presentations, company websites, interviews, webcasts, journal articles, scientific abstracts and reviews, relevant scientific meetings, clinical trial databases, and La Merie Publishing's proprietary database. Relevant information is presented in textual and tabular formats with disclosure of scientific references or by a hyperlink leading to the source of information.

Customized Update Service:The above described information service represents our standard module. At an incremental cost, the service can be exclusively widened and customized to specific client needs, e.g. preparation of a preferred presentation format, inclusion of a watch list for tracking, executive summary etc.

Contact us at publishing@lamerie.com to discuss your needs and our ideas of fulfilling them.

Download the full report: https://www.reportbuyer.com/product/4143726/About ReportbuyerReportbuyer is a leading industry intelligence solution that provides all market research reports from top publishershttp://www.reportbuyer.com

For more information: Sarah Smith Research Advisor at Reportbuyer.com Email: query@reportbuyer.com Tel: +44 208 816 85 48 Website: www.reportbuyer.com

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/rd-and-business-tracker-for-antibody-drug-conjugates-300357338.html

SOURCE ReportBuyer



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook